TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available July 11, 2014